Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
6
×
biotech
boston blog main
life sciences
new york blog main
san francisco blog main
boston top stories
cancer
clinical trials
deals
national top stories
san diego blog main
san francisco top stories
astellas pharma
fda
food and drug administration
healthcare
new york top stories
raleigh-durham blog main
san francisco
sanofi
seattle blog main
seattle top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
10x genomics
acid reflux
acid reflux disease
advance medical
american society of clinical oncology (asco)
american well
anti-inflammatory drugs
arcturus therapeutics
atlas venture
audentes therapeutics
avidity biosciences
avrobio
becton dickinson
best doctors
What
reach
6
×
cancer
cash
deal
drug
expand
ipo
long
medicines
acid
acquisition
add
adding
advance
ago
ahead
aims
ambien
american
annual
asco
attendees
attention
band
based
bid
biotech
biotechs
borders
bought
buys
camp’s
cancer’s
chicago
city
clinical
combinations
community’s
company
considering
Language
unset
Current search:
reach
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Somna Rebrands Acid Reflux Band in Bid to Reach More Patients
@xconomy.com
5 years ago
Teladoc Buys Advance Medical for $352M to Expand Telehealth Services
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More